Marcus Ballinger

17.1k citations
55 papers · 6.5k · 3 hit papers · h-index 29

Impact in

Papers in

    • Cancer Immunotherapy and Biomarkers 33
    • Colorectal Cancer Treatments and Studies 8
    • CAR-T cell therapy research 3
    • HER2/EGFR in Cancer Research 2

Marcus Ballinger

55 papers receiving 6.4k citations

Marcus Ballinger's Hit Papers

Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial 2020 · 420 citations
4200+3+6Years since publication50010001.5k2.0k

Peers

Marcus Ballinger
Comparison fields: 5 of 108
  • Oncology 4.1k
  • Pulmonary and Respiratory Medicine 1.7k
  • Immunology 1.1k
  • Cancer Research 528
  • Radiology, Nuclear Medicine and Imaging 542
Replace Michael Smylie with:
Michael Smylie Canada
Tibor Csőszi United States
Melissa L. Johnson United States
Drew Rasco United States
Bob T. Li United States
Jhanelle E. Gray United States
Hiroshi Nokihara Japan
Mark Ayers United States
Daniil Stroyakovskiy Russia
Hossein Borghaei United States
Marcus Ballinger relative to Michael Smylie Canada Michael Smylie's profile →
Citations per field
00.5×2.9×
Michael Smylie · 1×
Citations per year

Countries citing papers authored by Marcus Ballinger

Since Specialization
Citations

This map shows the geographic impact of Marcus Ballinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Ballinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Ballinger more than expected).

Fields of papers citing papers by Marcus Ballinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus Ballinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Ballinger. The network helps show where Marcus Ballinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Marcus Ballinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marcus Ballinger Line = papers co-authored together Marcus Ballinger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Hit paper breakdown →
20162139
2
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Hit paper breakdown →
20171580
3
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial
Hit paper breakdown →
2020420
4 2018245
5 2019177
6 2013139
7 1991139
8 2018133
9 2020114
10 2018108
11 2015102
12 199277
13 200964
14 201763
15 201961
16 201958
17 199257
18 199956
19 201854
20 199554

About Marcus Ballinger

Marcus Ballinger is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 55 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (33 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Genomics and Diagnostics (7 papers), Lung Cancer Treatments and Mutations (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), CAR-T cell therapy research (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (4.1k citations), Pulmonary and Respiratory Medicine (1.7k citations), Immunology (1.1k citations), Cancer Research (528 citations) and Radiology, Nuclear Medicine and Imaging (542 citations). Marcus Ballinger has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Alan Sandler, Achim Rittmeyer, Keunchil Park, Daniel S. Chen, Marcin Kowanetz, Julien Mazières, Louis Fehrenbacher, David C. Smith, Daniel Waterkamp and Alexander I. Spira. Their work appears in journals such as Journal of Clinical Oncology, Biochemistry, Journal of Thoracic Oncology, Clinical Lung Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact